Illustrative image – not actual.Ind Swift, a Chandigarh based
pharmaceutical company, plans to set up a R&D centre with an investment of
Rs.12.5 crore. The R&D centre would have facilities for bio-equivalence
studies, clinical trials for all three stages and toxicological studies.
The R&D centre would accept
contracts from other companies, besides undertaking R&D for the company.
